Long-term prophylactic (preventive) treatment with a fixed dose of Esperoct (turoctocog alfa pegol) — approved in the U.S. and…
Articles by Margarida Maia, PhD
Nearly one-fifth of patients with mild hemophilia admitted to treatment centers in the U.S. are female, according to a…
Women who are carriers for hemophilia — meaning they can pass the disease-causing mutation to their children — think a…
SCT800, a replacement therapy containing a man-made form of clotting factor VIII (FVIII), appears to be safe and effective…
Voncento — a highly concentrated mixture of Von Willebrand factor (VWF) and clotting factor VIII (FVIII) — was seen to…
Preventive, or prophylactic, treatment with Hemlibra (emicizumab) safely and effectively managed bleeding in adults and children with severe…